首页 | 本学科首页   官方微博 | 高级检索  
     


Incontinentia pigmenti in a male (XY) infant with long‐term follow up over 8 years
Authors:Yasushi Matsuzaki  Akiko Rokunohe  Satoko Minakawa  Kazuo Nomura  Hajime Nakano  Etsuro Ito  Daisuke Sawamura
Affiliation:1. Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;2. Nomura Dermatology Clinic, Hirosaki, Japan;3. Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Abstract:Incontinentia pigmenti (IP) is an X‐linked genodermatosis affecting the skin and other sites, including the teeth, nails, hair, eyes and nervous system defects in female patients. Generally lethal in males, there are only a few known cases of males surviving this condition. Nuclear factor (NF)‐κB essential modulator (NEMO), also known as inhibitor of kappa light polypeptide gene enhancer in B cells, kinase gamma (IKBKG), constitutes an essential activator of NF‐κB. Over 80% of female patients with IP carry a common deletion mutation involving exons 4–10 of the IKBKG/NEMO gene. We present the case of a male infant (XY) with IP with no concomitant complications. Polymerase chain reaction (PCR) assay showed that the exon 4–10 deletion band was significantly stronger in the skin sample than in blood. Subsequently, long‐range PCR was performed periodically to confirm the spontaneous regression of mutant cells from his blood. Over a period of 6 years, the 2.6‐kb mutant band gradually became weaker, but we did not confirm complete regression. Our patient was a healthy, 8‐year‐old male child with no complications despite the presence of a 2.6‐kb mutant band in his blood. Further follow up is necessary to assess for complications that may develop later.
Keywords:   inhibitor of kappa light polypeptide gene enhancer in B cells, kinase gamma     incontinentia pigmenti  male     nuclear factor kappaB essential modulator     somatic mosaicism
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号